Enzolytics (Enzolytics) Margin of Safety % (DCF Earnings Based) : N/A (As of May. 02, 2024)

View and export this data going back to 2008. Start your Free Trial

What is Enzolytics Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Enzolytics's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

Competitive Comparison of Enzolytics's Margin of Safety % (DCF Earnings Based)

For the Biotechnology subindustry, Enzolytics's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Enzolytics's Margin of Safety % (DCF Earnings Based) Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Enzolytics's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Enzolytics's Margin of Safety % (DCF Earnings Based) falls into.

Enzolytics Margin of Safety % (DCF Earnings Based) Related Terms

Thank you for viewing the detailed overview of Enzolytics's Margin of Safety % (DCF Earnings Based) provided by GuruFocus.com. Please click on the following links to see related term pages.

Enzolytics (Enzolytics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Enzolytics Inc (OTCPK:ENZC) » Definitions » Margin of Safety % (DCF Earnings Based)

Traded in Other Exchanges

N/A

Address

1101 Raintree Circle, Suite 130, Allen, TX, USA, 75013

Website

https://www.enzolytics.com

Enzolytics Inc is a biotechnology company, whose products consist of multiple distinct drug development proprietary technologies: Immunotherapy, immune modulators, fully human monoclonal antibodies, and an artificial intelligence (AI) platform for health care developments. It has clinically tested anti-HIV therapeutics. Additionally, the Company has created a proprietary cell line that produces fully human monoclonal antibodies that target and neutralizes the HIV virus.